Evidence map›Paper›PMID 32932412›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2020

Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.

Albert M Anderson, Jeong Hoon Jang, Kirk A Easley, Dietmar Fuchs, Magnus Gisslen, Henrik Zetterberg, Kaj Blennow, Ronald J Ellis, Donald Franklin, Robert K Heaton and 2 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07165639 (Association Between Inflammation Biomarkers and Neurocognitive Performance Among Adolescents Living With HIV in Eswatini), which is not on this map. Cited by 27 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 2 pooled it
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07165639 not yet recruitingnot on this mapstarted 2025, after this paper: background citation

Association Between Inflammation Biomarkers and Neurocognitive Performance Among Adolescents Living With HIV in Eswatini

TypeobservationalSponsorEswatini Nazarene Health InstitutionsRan2025 to 2026Enrolled80ConditionsHIV (Human Immunodeficiency Virus)
3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Low-Dose Cannabidiol Treatment does not Alter Cognitive Performance in the HIV-1 Transgenic Rat Model of NeuroHIV.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Biomarkers Unveiling the Interplay of Mind, Nervous System, and Immunity.Methods in molecular biology (Clifton, N.J.) · 2025
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 4 countries.

Albert M AndersonDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA.
Jeong Hoon JangDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN.
Kirk A EasleyDepartment of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Atlanta, GA.
Dietmar FuchsDivision of Biological Chemistry, Innsbruck Medical University, Innsbruck, Austria.
Magnus GisslenDepartment of Infectious Diseases, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Henrik ZetterbergDepartment of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, the Sahlgrenska Academy at the University of Gothenburg, Mölndal, Sweden.
Kaj BlennowClinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Mölndal, Sweden.
Ronald J EllisPsychiatry, and.
Donald FranklinPsychiatry, and.
Robert K HeatonPsychiatry, and.
Igor GrantPsychiatry, and.
Scott L LetendrePsychiatry, and.
Sahlgrenska University Hospital · SEEmory University · USADx NeuroSciencesIndiana University – Purdue University Indianapolis · USInnsbruck Medical University · ATUniversity of California, San Diego · US

Funding

Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jennifer E Iudicello · 2001 to 2026
$50.4M
SOURCES AND NEUROCOGNITIVE CORRELATES ON CSF HIV RNAR01MH058076 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ELLIS, RONALD J. · 1997 to 2010
$9.5M
Age related determinants of HAND: A 12 year follow-up of CHARTER participantsR01MH107345 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HEATON, ROBERT KERNACHAN, LETENDRE, SCOTT L · 2015 to 2021
$7.9M
Detect: A novel device to assess how HIV affects neurocognitive decline and postural instability in older adults at risk for Alzheimer's DiseaseR01AG062387 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOORE, RAEANNE CRISTINE · 2019 to 2023
$3.9M
Midcareer Investigator Award in Patient-Oriented NeuroAIDS ResearchK24MH097673 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2013 to 2017
$917k
Study of zidovudine addition in HIV-associated neurocognitive disordersK23MH095679 · NIMH · EMORY UNIVERSITY · PI ANDERSON, ALBERT · 2013 to 2017
$899k
Viral immunocapture and isolation of virus from CSF lymphoid and myeloid cells to better understand HIV in the central nervous systemR21MH118092 · NIMH · EMORY UNIVERSITY · PI ANDERSON, ALBERT · 2018 to 2019
$437k
Antiretroviral-Induced Immune Recovery and the Central Nervous SystemR21MH085610 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LETENDRE, SCOTT L · 2009 to 2010
$425k
NIAID NIH HHS P30 AI050409NIA NIH HHS R01 AG062387NIMH NIH HHS K23 MH095679NIMH NIH HHS K24 MH097673NIMH NIH HHS P30 MH062512NIMH NIH HHS R01 MH058076NIMH NIH HHS R01 MH107345NIMH NIH HHS R21 MH085610NIMH NIH HHS R21 MH118092
6 · The paper itself

Abstract

backgroundAcross many settings, lack of virologic control remains common in people with HIV (PWH) because of late presentation and lack of retention in care. This contributes to neuronal damage and neurocognitive impairment, which remains prevalent. More evidence is needed to understand these outcomes in both PWH and people without HIV (PWOH).

methodsWe recruited PWH initiating antiretroviral therapy and PWOH at 2 sites in the United States. One hundred eight adults were enrolled (56 PWOH and 52 PWH), most of whom had a second assessment at least 24 weeks later (193 total assessments). Tumor necrosis factor alpha, monocyte chemotactic protein-1 (MCP-1), neopterin, soluble CD14, and neurofilament light chain protein (NFL) were measured in plasma and cerebrospinal fluid (CSF). Using multivariate models including Bayesian model averaging, we analyzed factors associated with global neuropsychological performance (NPT-9) and CSF NFL at baseline and over time.

resultsAt baseline, higher CSF MCP-1 and plasma sCD14 were associated with worse NPT-9 in PWH, while CSF HIV RNA decrease was the only marker associated with improved NPT-9 over time. Among PWH, higher CSF neopterin was most closely associated with higher NFL. Among PWOH, higher CSF MCP-1 was most closely associated with higher NFL. After antiretroviral therapy initiation, decrease in CSF MCP-1 was most closely associated with NFL decrease.

conclusionMonocyte-associated CSF biomarkers are highly associated with neuronal damage in both PWH and PWOH. More research is needed to evaluate whether therapies targeting monocyte-associated inflammation may ameliorate HIV-associated neurobehavioral diseases.

Indexed as

AdultBiomarkersCase-Control StudiesFemaleHIV InfectionsHumansInflammationLongitudinal StudiesMaleNeurocognitive DisordersNeurofilament ProteinsNeuropsychological TestsBiomarkersNeurofilament Proteins

Identifiers

PMID32932412
PMCPMC8725606
OpenAlexW3087560759

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.